Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Gene |
RCV000483272 | SCV000569882 | likely pathogenic | not provided | 2016-04-01 | criteria provided, single submitter | clinical testing | Although the c.81704delC likely pathogenic variant in the TTN gene has not been reported to our knowledge, this variant causes a shift in reading frame starting at codon Proline 27235, changing it to a Glutamine, and creating a premature stop codon at position 2 of the new reading frame, denoted p.Pro27235GlnfsX2. This variant is expected to result in either an abnormal, truncated protein product or loss of protein from this allele through nonsense-mediated mRNA decay. Other frameshift variants in the TTN gene have been reported in HGMD in association with cardiomyopathy (Stenson et al., 2014). Furthermore, the c.81704delC variant was not observed in approximately 6,100 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. However, truncating variants in the TTN gene have been reported in approximately 3% of control alleles (Herman D et al., 2012). Nevertheless, c.81704delC is located in the A-band region of titin, where the majority of truncating pathogenic variants associated with DCM have been reported (Herman et al., 2012). |